Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: February 18, 2026
Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study.
Journal: Journal of cancer research and clinical oncology
Published: April 21, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer.
Journal: Journal for immunotherapy of cancer
Published: March 19, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
Journal: ESMO open
Published: September 04, 2024
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: March 05, 2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches.
Journal: Journal of neuro-oncology
Published: February 27, 2024
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 19, 2023
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Journal: Neurosurgery
Published: April 20, 2023
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
Journal: The oncologist
Published: July 26, 2021
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: October 18, 2017
Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.
Journal: Oncoimmunology
Published: November 07, 2016
EXPRESSION OF PFKFB, HK2, NAMPT, TSPAN13 AND HSPB8 GENES IN PEDIATRIC GLIOMA
Journal: Likars'ka sprava
Published: August 06, 2016
Last Updated: 09/26/2026